1.
Zaenglein A, Del Rosso J. An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period. J of Skin [Internet]. 2018Feb.23 [cited 2020Oct.21];2(S1):S33. Available from: https://jofskin.org/index.php/skin/article/view/304